Hamilton Thorne Ltd. (HTLZF)
USD 1.59
(N/A%)
USD 1.59
(N/A%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 110.16 Million USD | 25.28% |
| 2022 | 87.93 Million USD | 17.15% |
| 2021 | 75.06 Million USD | 7.53% |
| 2020 | 69.8 Million USD | 20.43% |
| 2019 | 57.96 Million USD | 21.91% |
| 2018 | 47.55 Million USD | 25.76% |
| 2017 | 37.81 Million USD | 208.84% |
| 2016 | 12.24 Million USD | 72.26% |
| 2015 | 7.1 Million USD | 96.88% |
| 2014 | 3.6 Million USD | 71.9% |
| 2013 | 2.09 Million USD | 2.62% |
| 2012 | 2.04 Million USD | -24.43% |
| 2011 | 2.7 Million USD | 6.82% |
| 2010 | 2.53 Million USD | -3.54% |
| 2009 | 2.62 Million USD | 158.1% |
| 2008 | 1.01 Million USD | -38.41% |
| 2007 | 1.65 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 107.81 Million USD | 0.85% |
| 2024 Q1 | 106.9 Million USD | -2.96% |
| 2023 Q2 | 91.22 Million USD | 4.63% |
| 2023 Q1 | 87.18 Million USD | -0.85% |
| 2023 Q4 | 110.16 Million USD | 20.75% |
| 2023 Q3 | 91.23 Million USD | 0.01% |
| 2023 FY | 110.16 Million USD | 25.28% |
| 2022 FY | 87.93 Million USD | 17.15% |
| 2022 Q2 | 70.29 Million USD | -4.39% |
| 2022 Q3 | 70.27 Million USD | -0.04% |
| 2022 Q4 | 87.93 Million USD | 25.13% |
| 2022 Q1 | 73.52 Million USD | -2.04% |
| 2021 Q3 | 75.14 Million USD | 7.64% |
| 2021 Q2 | 69.81 Million USD | 2.21% |
| 2021 Q1 | 68.3 Million USD | -2.15% |
| 2021 FY | 75.06 Million USD | 7.53% |
| 2021 Q4 | 75.06 Million USD | -0.11% |
| 2020 Q1 | 59.99 Million USD | 3.49% |
| 2020 FY | 69.8 Million USD | 20.43% |
| 2020 Q2 | 64.26 Million USD | 7.11% |
| 2020 Q3 | 66.75 Million USD | 3.88% |
| 2020 Q4 | 69.8 Million USD | 4.58% |
| 2019 Q1 | 51.09 Million USD | 7.46% |
| 2019 Q2 | 51.1 Million USD | 0.02% |
| 2019 Q4 | 57.96 Million USD | 4.69% |
| 2019 FY | 57.96 Million USD | 21.91% |
| 2019 Q3 | 55.37 Million USD | 8.35% |
| 2018 Q1 | 38.9 Million USD | 2.89% |
| 2018 Q4 | 47.55 Million USD | 3.75% |
| 2018 FY | 47.55 Million USD | 25.76% |
| 2018 Q3 | 45.83 Million USD | 18.47% |
| 2018 Q2 | 38.68 Million USD | -0.55% |
| 2017 Q1 | 12.08 Million USD | -1.27% |
| 2017 Q4 | 37.81 Million USD | 18.35% |
| 2017 FY | 37.81 Million USD | 208.84% |
| 2017 Q3 | 31.94 Million USD | 0.61% |
| 2017 Q2 | 31.75 Million USD | 162.71% |
| 2016 Q1 | 7.17 Million USD | 1.0% |
| 2016 FY | 12.24 Million USD | 72.26% |
| 2016 Q4 | 12.24 Million USD | 2.29% |
| 2016 Q2 | 7.65 Million USD | 6.62% |
| 2016 Q3 | 11.96 Million USD | 56.39% |
| 2015 Q1 | 3.75 Million USD | 3.91% |
| 2015 FY | 7.1 Million USD | 96.88% |
| 2015 Q2 | 5.48 Million USD | 46.3% |
| 2015 Q4 | 7.1 Million USD | 24.85% |
| 2015 Q3 | 5.69 Million USD | 3.74% |
| 2014 Q1 | 2.18 Million USD | 4.28% |
| 2014 FY | 3.6 Million USD | 71.9% |
| 2014 Q3 | 2.28 Million USD | 3.52% |
| 2014 Q4 | 3.6 Million USD | 58.2% |
| 2014 Q2 | 2.2 Million USD | 0.64% |
| 2013 Q4 | 2.09 Million USD | 17.05% |
| 2013 FY | 2.09 Million USD | 2.62% |
| 2013 Q1 | 1.85 Million USD | -9.38% |
| 2013 Q2 | 1.95 Million USD | 5.6% |
| 2013 Q3 | 1.79 Million USD | -8.39% |
| 2012 Q3 | 1.92 Million USD | 1.09% |
| 2012 Q4 | 2.04 Million USD | 6.17% |
| 2012 Q2 | 1.9 Million USD | -14.15% |
| 2012 Q1 | 2.22 Million USD | -17.98% |
| 2012 FY | 2.04 Million USD | -24.43% |
| 2011 Q2 | 2.32 Million USD | -7.02% |
| 2011 FY | 2.7 Million USD | 6.82% |
| 2011 Q4 | 2.7 Million USD | -7.75% |
| 2011 Q3 | 2.93 Million USD | 26.21% |
| 2011 Q1 | 2.5 Million USD | -1.32% |
| 2010 Q4 | 2.53 Million USD | -11.16% |
| 2010 Q1 | 2.09 Million USD | -20.16% |
| 2010 FY | 2.53 Million USD | -3.54% |
| 2010 Q3 | 2.85 Million USD | 46.21% |
| 2010 Q2 | 1.95 Million USD | -6.99% |
| 2009 Q3 | 2.09 Million USD | 44.33% |
| 2009 Q2 | 1.44 Million USD | 43.79% |
| 2009 Q1 | 1 Million USD | -1.09% |
| 2009 FY | 2.62 Million USD | 158.1% |
| 2009 Q4 | 2.62 Million USD | 25.74% |
| 2008 Q1 | 1.63 Million USD | -1.21% |
| 2008 Q3 | 1.11 Million USD | -26.22% |
| 2008 Q4 | 1.01 Million USD | -8.67% |
| 2008 FY | 1.01 Million USD | -38.41% |
| 2008 Q2 | 1.51 Million USD | -7.48% |
| 2007 Q4 | 1.65 Million USD | -5.05% |
| 2007 Q3 | 1.74 Million USD | 5.84% |
| 2007 FY | 1.65 Million USD | 0.0% |
| 2007 Q2 | 1.64 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Avitar, Inc. | 1.74 Million USD | -6202.887% |
| BioElectronics Corporation | 144.38 Thousand USD | -76196.805% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 999 Thousand USD | -10927.37% |
| Medical Supply International USA, Inc. | 870.77 Thousand USD | -12551.252% |
| Polarean Imaging plc | 10.86 Million USD | -913.718% |
| AVITA Medical, Inc. | 144.33 Million USD | 23.678% |
| Manhattan Scientifics, Inc. | 316 Thousand USD | -34761.845% |
| Össur hf. | 1.39 Billion USD | 92.096% |
| Zecotek Photonics Inc. | 2.57 Million USD | -4181.695% |
| QHSLab, Inc. | 1.68 Million USD | -6451.762% |
| Wellstar International, Inc. | 957.89 Thousand USD | -11400.611% |
| Össur hf. | 1.39 Billion USD | 92.096% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 102.92 Million USD | -7.037% |
| Escalon Medical Corp. | 4.75 Million USD | -2215.367% |
| Aurora Spine Corporation | 11.92 Million USD | -823.899% |
| BrainsWay Ltd. | 62.97 Million USD | -74.94% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 2.85 Million USD | -3761.246% |
| Vivos Inc. | 1.61 Million USD | -6741.922% |
| MicroPort Scientific Corporation | 3.93 Billion USD | 97.198% |
| Kelyniam Global, Inc. | 1.63 Million USD | -6647.341% |
| REMSleep Holdings, Inc. | 1.2 Million USD | -9032.235% |
| CYduct Diagnostics, Inc. | 54.74 Thousand USD | -201119.097% |
| Nanomix Corporation | 982.05 Thousand USD | -11117.644% |
| Theraclion SA | 18.66 Million EUR | -490.259% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 182.18 Thousand USD | -60369.553% |
| Positron Corporation | 1.76 Million USD | -6132.197% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 748.38 Thousand USD | -14620.194% |
| Lombard Medical, Inc. | 67.76 Million USD | -62.562% |
| ALR Technologies Inc. | 193.21 Thousand USD | -56915.393% |
| Stratec SE | 529.71 Million USD | 79.203% |
| Vycor Medical, Inc. | 992.29 Thousand USD | -11001.85% |
| Heart Tronics, Inc. | 4.04 Million USD | -2620.8% |
| Nu-Med Plus, Inc. | 2.21 Million USD | -4880.185% |
| Perimeter Medical Imaging AI, Inc. | 20.54 Million USD | -436.3% |
| SANUWAVE Health, Inc. | 22.41 Million USD | -391.45% |
| VMS Rehab Systems, Inc. | 4.45 USD | -2475582619.101% |
| Guided Therapeutics, Inc. | 1.66 Million USD | -6500.565% |
| Ingen Technologies, Inc. | 737.73 Thousand USD | -14832.595% |
| Odyssey Group International, Inc. | 455.79 Thousand USD | -24069.619% |
| United American Healthcare Corporation | 10.37 Million USD | -961.407% |
| ECGI Holdings, Inc. | 5.2 Million USD | -2017.954% |
| Capital Group Holdings, Inc. | 33.79 Thousand USD | -325885.178% |
| ADM Tronics Unlimited, Inc. | 2.13 Million USD | -5050.886% |
| Urologix, Inc. | 5.66 Million USD | -1843.946% |
| Rapid Therapeutic Science Laboratories, Inc. | 2.25 Million USD | -4786.206% |
| Nexeon MedSystems Inc. | 20.35 Million USD | -441.305% |
| SS Innovations International, Inc. | 25.47 Million USD | -332.368% |
| Qualis Innovations, Inc. | 2431.00 USD | -4531509.667% |
| Smith & Nephew plc | 9.97 Billion USD | 98.895% |
| NIOX Group Plc | 116.47 Million USD | 5.422% |
| Fuse Medical, Inc. | 16.25 Million USD | -577.546% |
| Broncus Holding Corporation | 195.75 Million USD | 43.723% |
| Brain Scientific Inc. | 11.74 Million USD | -838.07% |
| Pressure BioSciences, Inc. | 1.04 Million USD | -10394.994% |
| Health Logic Interactive Inc. | 28.73 Thousand USD | -383277.174% |